Lung-Accumulating Mucin 5AC Silencing by Noninflammatory Lipid Nanoparticles for Asthma Treatment
Abstract
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Advancements in Transdermal Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Wuya College of Innovation
Shenyang Pharmaceutical University
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences
Peking University
Beijing Key Laboratory of Molecular Pharmaceutics, School of Pharmaceutical Sciences
Department of Respiratory and Critical Care Medicine
Peking University Third Hospital
Beijing Tide Pharmaceutical Co., Ltd.
University of North Carolina
Department of Thoracic Surgery Peking University People’s Hospital, 11 Xizhimen South Street, Beijing 100044, China
Thoracic Oncology Institute Peking University People’s Hospital Beijing
Clinical Stem Cell Research Center
Research Center for Chronic Airway Diseases
Peking University Health Science Center
Key Laboratory of Colloid, Interface and Chemical Thermodynamics
Institute of Chemistry, Chinese Academy of Sciences
Peking University-Yunnan Baiyao International Medical Research Center
Funding
National Key Research and Development Program of China · Liaoning Revitalization Talents Program · Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park · Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China · Project of China-Japan Joint International Laboratory of Advanced Drug Delivery System Research and Translation of Liaoning Province